Pneumococcal Polysaccharide Conjugate Vaccine
Posted by: DrugsNews on: 29 Sep, 2009
- In: Drugs News
- 1 Comment
Prevenar 13 – Pneumococcal Polysaccharide Conjugate Vaccine – receives positive opinion from European Regulators for aproval for active immunization of children aged 6 weeks to 5 years for the prevention of invasive pneumococcal disease, as well as pneumonia and otitis media (middle ear infection) caused by 13 pneumococcal serotypes.
The company (Wyeth) claims that [...]
